Treatment and Survival Outcomes for Patients with Colorectal Peritoneal Metastases Deemed Ineligible for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Results of a Retrospective Study
- Michelle V. Dietz*
- , Merijn J. Ziekman
- , Job P. van Kooten
- , Alexandra R.M. Brandt-Kerkhof
- , Esther van Meerten
- , Cornelis Verhoef
- , Eva V.E. Madsen
*Corresponding author for this work
Research output: Contribution to journal › Article › Academic › peer-review
2
Citations
(Scopus)